Dhampur Bio Organics Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: September 6, 2025, 12:25 am

Quick Insight

Dhampur Bio Organics Ltd, operating in the sugar industry, currently has a market price of 85.0 with a market capitalization of 565 Cr. The company's financial health appears concerning, with a low ROE of 1.56% and ROCE of 3.97%. Furthermore, its high level of borrowings at ₹1,162 Cr raises questions about its leverage and ability to meet obligations, especially considering a CCC of 270 days. With a P/BV of 0.43x and an ICR of 2.06x, investors may view the stock as undervalued, but caution is warranted due to the company's weak profitability and high debt levels.

Competitors of Dhampur Bio Organics Ltd

All Competitor Stocks of Dhampur Bio Organics Ltd

Quarterly Result

Last Updated: August 19, 2025, 8:10 pm

Below is a detailed analysis of the quarterly data for Dhampur Bio Organics Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 526.00 Cr.. The value appears strong and on an upward trend. It has increased from 464.00 Cr. (Mar 2025) to 526.00 Cr., marking an increase of 62.00 Cr..
• For Expenses, as of Jun 2025, the value is 524.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 369.00 Cr. (Mar 2025) to 524.00 Cr., marking an increase of 155.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 1.00 Cr.. The value appears to be declining and may need further review. It has decreased from 96.00 Cr. (Mar 2025) to 1.00 Cr., marking a decrease of 95.00 Cr..
• For OPM %, as of Jun 2025, the value is 0.00%. The value appears to be declining and may need further review. It has decreased from 21.00% (Mar 2025) to 0.00%, marking a decrease of 21.00%.
• For Other Income, as of Jun 2025, the value is 2.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Mar 2025) to 2.00 Cr., marking an increase of 1.00 Cr..
• For Interest, as of Jun 2025, the value is 22.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 20.00 Cr. (Mar 2025) to 22.00 Cr., marking an increase of 2.00 Cr..
• For Depreciation, as of Jun 2025, the value is 14.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 16.00 Cr. (Mar 2025) to 14.00 Cr., marking a decrease of 2.00 Cr..
• For Profit before tax, as of Jun 2025, the value is -33.00 Cr.. The value appears to be declining and may need further review. It has decreased from 61.00 Cr. (Mar 2025) to -33.00 Cr., marking a decrease of 94.00 Cr..
• For Tax %, as of Jun 2025, the value is -33.00%. The value appears to be improving (decreasing) as expected. It has decreased from 26.00% (Mar 2025) to -33.00%, marking a decrease of 59.00%.
• For Net Profit, as of Jun 2025, the value is -22.00 Cr.. The value appears to be declining and may need further review. It has decreased from 45.00 Cr. (Mar 2025) to -22.00 Cr., marking a decrease of 67.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is -3.31. The value appears to be declining and may need further review. It has decreased from 6.75 (Mar 2025) to -3.31, marking a decrease of 10.06.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 1:53 pm

Growth

Last Updated: September 5, 2025, 3:11 pm

Balance Sheet

Last Updated: July 25, 2025, 1:27 pm

Below is a detailed analysis of the balance sheet data for Dhampur Bio Organics Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 66.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 66.00 Cr..
• For Reserves, as of Mar 2025, the value is 945.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 945.00 Cr..
• For Borrowings, as of Mar 2025, the value is 1,162.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 1,057.00 Cr. (Mar 2024) to 1,162.00 Cr., marking an increase of 105.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 223.00 Cr.. The value appears to be improving (decreasing). It has decreased from 244.00 Cr. (Mar 2024) to 223.00 Cr., marking a decrease of 21.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 2,398.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,313.00 Cr. (Mar 2024) to 2,398.00 Cr., marking an increase of 85.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 1,076.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,036.00 Cr. (Mar 2024) to 1,076.00 Cr., marking an increase of 40.00 Cr..
• For CWIP, as of Mar 2025, the value is 79.00 Cr.. The value appears strong and on an upward trend. It has increased from 13.00 Cr. (Mar 2024) to 79.00 Cr., marking an increase of 66.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 1,242.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,263.00 Cr. (Mar 2024) to 1,242.00 Cr., marking a decrease of 21.00 Cr..
• For Total Assets, as of Mar 2025, the value is 2,398.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,313.00 Cr. (Mar 2024) to 2,398.00 Cr., marking an increase of 85.00 Cr..

However, the Borrowings (1,162.00 Cr.) are higher than the Reserves (945.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

No data available for the No. of Shareholders chart.

Key Financial Ratios

After reviewing the key financial ratios for Dhampur Bio Organics Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 2.21. This value is below the healthy minimum of 5. It has decreased from 7.00 (Mar 24) to 2.21, marking a decrease of 4.79.
• For Diluted EPS (Rs.), as of Mar 25, the value is 2.21. This value is below the healthy minimum of 5. It has decreased from 7.00 (Mar 24) to 2.21, marking a decrease of 4.79.
• For Cash EPS (Rs.), as of Mar 25, the value is 10.33. This value is within the healthy range. It has decreased from 14.46 (Mar 24) to 10.33, marking a decrease of 4.13.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 152.39. It has increased from 152.35 (Mar 24) to 152.39, marking an increase of 0.04.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 152.39. It has increased from 152.35 (Mar 24) to 152.39, marking an increase of 0.04.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 280.39. It has decreased from 280.83 (Mar 24) to 280.39, marking a decrease of 0.44.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 20.86. This value is within the healthy range. It has decreased from 24.15 (Mar 24) to 20.86, marking a decrease of 3.29.
• For PBIT / Share (Rs.), as of Mar 25, the value is 12.74. This value is within the healthy range. It has decreased from 16.69 (Mar 24) to 12.74, marking a decrease of 3.95.
• For PBT / Share (Rs.), as of Mar 25, the value is 2.37. This value is within the healthy range. It has decreased from 9.86 (Mar 24) to 2.37, marking a decrease of 7.49.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 2.21. This value is within the healthy range. It has decreased from 7.00 (Mar 24) to 2.21, marking a decrease of 4.79.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 2.21. This value is within the healthy range. It has decreased from 7.00 (Mar 24) to 2.21, marking a decrease of 4.79.
• For PBDIT Margin (%), as of Mar 25, the value is 7.43. This value is below the healthy minimum of 10. It has decreased from 8.59 (Mar 24) to 7.43, marking a decrease of 1.16.
• For PBIT Margin (%), as of Mar 25, the value is 4.54. This value is below the healthy minimum of 10. It has decreased from 5.94 (Mar 24) to 4.54, marking a decrease of 1.40.
• For PBT Margin (%), as of Mar 25, the value is 0.84. This value is below the healthy minimum of 10. It has decreased from 3.51 (Mar 24) to 0.84, marking a decrease of 2.67.
• For Net Profit Margin (%), as of Mar 25, the value is 0.78. This value is below the healthy minimum of 5. It has decreased from 2.49 (Mar 24) to 0.78, marking a decrease of 1.71.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 0.78. This value is below the healthy minimum of 8. It has decreased from 2.49 (Mar 24) to 0.78, marking a decrease of 1.71.
• For Return on Networth / Equity (%), as of Mar 25, the value is 1.45. This value is below the healthy minimum of 15. It has decreased from 4.59 (Mar 24) to 1.45, marking a decrease of 3.14.
• For Return on Capital Employeed (%), as of Mar 25, the value is 6.42. This value is below the healthy minimum of 10. It has decreased from 8.78 (Mar 24) to 6.42, marking a decrease of 2.36.
• For Return On Assets (%), as of Mar 25, the value is 0.61. This value is below the healthy minimum of 5. It has decreased from 2.01 (Mar 24) to 0.61, marking a decrease of 1.40.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.23. This value is within the healthy range. It has increased from 0.17 (Mar 24) to 0.23, marking an increase of 0.06.
• For Total Debt / Equity (X), as of Mar 25, the value is 1.14. This value exceeds the healthy maximum of 1. It has increased from 1.03 (Mar 24) to 1.14, marking an increase of 0.11.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.79. It has decreased from 0.84 (Mar 24) to 0.79, marking a decrease of 0.05.
• For Current Ratio (X), as of Mar 25, the value is 1.14. This value is below the healthy minimum of 1.5. It has decreased from 1.19 (Mar 24) to 1.14, marking a decrease of 0.05.
• For Quick Ratio (X), as of Mar 25, the value is 0.12. This value is below the healthy minimum of 1. It has decreased from 0.16 (Mar 24) to 0.12, marking a decrease of 0.04.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.25. This value is below the healthy minimum of 4. It has decreased from 1.69 (Mar 24) to 1.25, marking a decrease of 0.44.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 49.96 (Mar 24) to 0.00, marking a decrease of 49.96.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 24.20 (Mar 24) to 0.00, marking a decrease of 24.20.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 50.04 (Mar 24) to 0.00, marking a decrease of 50.04.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 75.80 (Mar 24) to 0.00, marking a decrease of 75.80.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 2.06. This value is below the healthy minimum of 3. It has decreased from 3.54 (Mar 24) to 2.06, marking a decrease of 1.48.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.25. This value is below the healthy minimum of 3. It has decreased from 2.03 (Mar 24) to 1.25, marking a decrease of 0.78.
• For Enterprise Value (Cr.), as of Mar 25, the value is 1,553.77. It has decreased from 1,776.49 (Mar 24) to 1,553.77, marking a decrease of 222.72.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.83. This value is below the healthy minimum of 1. It has decreased from 0.95 (Mar 24) to 0.83, marking a decrease of 0.12.
• For EV / EBITDA (X), as of Mar 25, the value is 11.22. This value is within the healthy range. It has increased from 11.08 (Mar 24) to 11.22, marking an increase of 0.14.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.23. This value is below the healthy minimum of 1. It has decreased from 0.40 (Mar 24) to 0.23, marking a decrease of 0.17.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 50.03 (Mar 24) to 0.00, marking a decrease of 50.03.
• For Price / BV (X), as of Mar 25, the value is 0.43. This value is below the healthy minimum of 1. It has decreased from 0.75 (Mar 24) to 0.43, marking a decrease of 0.32.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.23. This value is below the healthy minimum of 1. It has decreased from 0.40 (Mar 24) to 0.23, marking a decrease of 0.17.
• For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has decreased from 0.06 (Mar 24) to 0.03, marking a decrease of 0.03.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness